Suggestions
Sam Ecker
Director of Revenue at SmithRx
Sam Ecker is the Chief Financial Officer at ModRetro, a company based in San Francisco, California.2 He has a diverse professional background in the technology and healthcare sectors.
Professional Experience
Prior to his role at ModRetro, Sam Ecker was involved with SmithRx, a healthcare technology company focused on lowering costs.1 At SmithRx, he held the position of Director of Revenue.3 This experience in healthcare technology likely contributes to his current role in the financial leadership of ModRetro.
Education
Sam Ecker attended Stanford University, though the specific details of his degree are not mentioned in the provided information.1
Skills and Expertise
Given his roles in financial leadership and revenue management, Sam Ecker likely has expertise in:
- Financial strategy and management
- Healthcare technology
- Revenue optimization
- Business development
It's worth noting that Sam Ecker appears to be active on professional networking platforms, maintaining a presence on LinkedIn with the username sam-ecker-80325030.1
Highlights
I’m happy to share that I’m starting a new position as Director of Revenue at SmithRx!
Thank you to Matt Grimm, Trae Stephens, Brian Schimpf, Matthew Steckman, and Palmer Luckey for taking a chance on me at Anduril Industries in the early days and to the countless colleagues I was fortunate to get to know along the way. The Anduril experience is impossible to put into words. I'm proud to have been a part of the company and mission and will be cheering all my former colleagues on as they continue to build a category defining company delivering much-needed innovation in defense.
I was pushed towards health care technology (as many are) by personal experiences over the last two years. We all are exposed to the health care system to varying degrees over the course of our lives and my brushes with it, despite thankfully mostly positive outcomes, were complicated and frustrating. It became clear to me this was where I wanted to focus the next chunk of my career.
Transitioning to a brand new opaque industry is not easy. Thank you to Trae Stephens, Matt Grimm, Ian Koons, Nate Collins, Prateesh Maheshwari, Colin Greenspon, Katherine Walker, Beau Palin, Brad Lightcap, and many others who were so generous with their networks, guidance, and time as I navigated this next step.
I'm thrilled to have found SmithRx and am looking forward to working with Sam Slaughter, Jake Frenz, Jeff Snow, Billy Sloan, and the rest of the team to bring transparency to drug pricing. The system as it exists today for delivering drugs to Americans is way too complicated and patients end up suffering as a result. SmithRx is changing this with their drug acquisition technology stack, full pass-through model, and patient-centered programs for saving health plans money.
If you're working in a similar space in health care or thinking about a transition to the industry yourself I'd love to connect for a conversation. Please don't hesitate to reach out to [email protected].
